Sponsored Content by Alliance for Pharmacy Compounding
Patient access to cBHT is being threatened. Here’s how you can help.
We need every pharmacist, every prescriber, every patient whose lives have been made better by compounded hormones to add their voice to the chorus demanding continued access to this essential medical therapy.
UNDERSTAND THE ISSUE
New restrictions could be devastating the health of our patients. Not to mention our industry. If you are aware of the issue, but unclear on the details, here are a few important sources to read:
- The NASEM cBHT report. While biased, this remains an important document to read for understanding what’s at stake.
- Alliance for Pharmacy Compounding (APC) news release with essential background on the NASEM cBHT report.
- The Berkeley Research Group analysis of the NASEM report, funded by the Pharmacy Compounding Foundation.
- Reed Smith LLP, a dynamic international law firm, wrote a comment letter to the FDA based on results of the firm’s FOIA request.
INVEST IN THE CAMPAIGN TO SAVE cBHT
Support the Alliance for Pharmacy Compounding’s Media Campaign Fund is a three–year, consumer– and policymaker–focused initiative aimed at confronting FDA’s threat to restrict compounded hormones and at communicating the profound good pharmacy compounding plays in the lives of millions of patients.
The campaign puts a patient face on compounding. Its tagline is ‘Compounding the joy of living – one patient at a time.’ The effort funded by gifts from pharmacy compounders, prescribers, patients, related organizations, and service and supply vendors in the compounding space.
Healthcare providers can support the campaign with a reoccurring gift or a one time gift of any amount by sending a donation.
Patients who have benefited from compounded hormone therapies can show their support by sharing a testimonial.
Everyone can join the fight by urging members of congress to protect access to compounded hormones. Find you representative.
For more information, visit the website dedicated to this campaign at www.compounding.com
Connect with Us
If you have any questions or would like additional information, please contact Innovation Compounding at 1-800-547-1399, Monday-Friday, 9 a.m. to 5 p.m. EST, excluding all major holidays.
Medical Disclaimer This content is for informational and educational purposes only. It is not intended to provide medical advice or take the place of such information or treatment from a personal physician. All readers/viewers of this content are advised to consult their doctors or qualified health professionals regarding specific health questions. Neither Innovation Compounding, Inc. nor the publisher of this content takes responsibility for possible health consequences of any person or persons reading or following the information in this educational content. All viewers of this content, especially those taking prescription or over-the-counter medications, should consult their physicians before beginning any medication, nutritional supplement, diet, or health regimen. Innovation Compounding does not make or intend to make any claims to efficacy or safety of compounded products for specific conditions or disease states, as compounded products are not FDA-approved for these conditions.
Sources & References
“Compounding Pharmacies Market Share: Statistics Report 2027.” Global Market Insights Inc.,
Lianna Matt McLernon | News Writer | CIDRAP News | Jul 27, 2021. “Drug Compounding
Helped Address Drug Gaps during COVID.” CIDRAP, 27 July 2021,
Staff. “Compounding Pharmacies Step into the Breach Created by the Coronavirus Pandemic.”
U.S. Pharmacist – The Leading Journal in Pharmacy, 15 May 2020,